| Cells release subpopulations of exosomes with distinct molecular and biological properties E Willms, HJ Johansson, I Mäger, Y Lee, KEM Blomberg, M Sadik, ... Scientific reports 6 (1), 22519, 2016 | 971 | 2016 |
| Hyaluronan nanoparticles selectively target plaque-associated macrophages and improve plaque stability in atherosclerosis TJ Beldman, ML Senders, A Alaarg, C Pérez-Medina, J Tang, Y Zhao, ... ACS nano 11 (6), 5785-5799, 2017 | 171 | 2017 |
| Red blood cell vesiculation in hereditary hemolytic anemia A Alaarg, RM Schiffelers, WW van Solinge, R Van Wijk Frontiers in physiology 4, 365, 2013 | 129 | 2013 |
| Immune cell screening of a nanoparticle library improves atherosclerosis therapy J Tang, S Baxter, A Menon, A Alaarg, BL Sanchez-Gaytan, F Fay, Y Zhao, ... Proceedings of the National Academy of Sciences 113 (44), E6731-E6740, 2016 | 118 | 2016 |
| Nanobody-facilitated multiparametric PET/MRI phenotyping of atherosclerosis ML Senders, S Hernot, G Carlucci, JC van de Voort, F Fay, C Calcagno, ... JACC: Cardiovascular Imaging 12 (10), 2015-2026, 2019 | 75 | 2019 |
| A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis A Alaarg, ML Senders, A Varela-Moreira, C Pérez-Medina, Y Zhao, ... Journal of controlled release 262, 47-57, 2017 | 54 | 2017 |
| Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment A Alaarg, NY Jordan, JJF Verhoef, JM Metselaar, G Storm, RJ Kok International journal of nanomedicine, 5027-5040, 2016 | 53 | 2016 |
| Applying nanomedicine in maladaptive inflammation and angiogenesis A Alaarg, C Pérez-Medina, JM Metselaar, M Nahrendorf, ZA Fayad, ... Advanced drug delivery reviews 119, 143-158, 2017 | 50 | 2017 |
| Real‐time monitoring of nanoparticle formation by FRET imaging BL Sanchez‐Gaytan, F Fay, S Hak, A Alaarg, ZA Fayad, C Pérez‐Medina, ... Angewandte Chemie 129 (11), 2969-2972, 2017 | 46 | 2017 |
| Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis FM van der Valk, DM Schulte, S Meiler, J Tang, KH Zheng, ... Nanomedicine: nanotechnology, biology and medicine 12 (6), 1463-1470, 2016 | 45 | 2016 |
| Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep 6: 22519 E Willms, HJ Johansson, I Mäger, Y Lee, KEM Blomberg, M Sadik, ... | 30 | 2016 |
| Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep. 2016; 6: 22519 E Willms, HJ Johansson, I Mager, Y Lee, KE Blomberg, M Sadik, A Alaarg, ... Regardless of cellular source, EVs are heterogeneous populations with …, 0 | 26 | |
| Investigating the cellular specificity in tumors of a surface-converting nanoparticle by multimodal imaging F Fay, L Hansen, SJCG Hectors, BL Sanchez-Gaytan, Y Zhao, J Tang, ... Bioconjugate chemistry 28 (5), 1413-1421, 2017 | 14 | 2017 |
| Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques A Alaarg, KH Zheng, FM van der Valk, AE Da Silva, M Versloot, ... Vascular pharmacology 82, 51-59, 2016 | 10 | 2016 |
| Comparative analysis of nanosystems’ effects on human endothelial and monocytic cell functions J Matuszak, P Dörfler, S Lyer, H Unterweger, M Juenet, C Chauvierre, ... Nanotoxicology 12 (9), 957-974, 2018 | 9 | 2018 |
| Design of Clinical In-Use Studies S Gupta, A Alaarg, Z Wu, X Lu, VK Garripelli, H Dong, S Sawilla, B Patel, ... Development of Biopharmaceutical Drug-Device Products 35, 431-459, 2020 | 5 | 2020 |
| Targeted liposomal drug delivery to inhibit atherosclerotic plaque inflammation A Alaarg, AAJ Hamers, M Versloot, ME Lobatto, WJM Mulder, ESG Stroes, ... Atherosclerosis 241 (1), e87, 2015 | 5 | 2015 |
| A microdosing framework for absolute bioavailability assessment of poorly soluble drugs: a case study on cold‐labeled venetoclax, from chemistry to the clinic A Alaarg, R Menon, D Rizzo, Y Liu, J Bien, T Elkinton, T Grieme, ... Clinical and Translational Science 15 (1), 244-254, 2022 | 4 | 2022 |
| Nanobody-Facilitated Multiparametric PET/MRI phenotyping of experimental atherosclerosis M Senders, S Hernot, G Carlucci, J van de Voort, F Fay, C Calcagno, ... | | 2018 |
| Targeted therapeutics in inflammatory atherosclerosis AMSA Alaarg | | 2017 |
Willem J. M. MulderRadboud University Medical Center在 radboudumc.nl 的电子邮件经过验证
